These podcasts are intended for hematologists, hematologists/oncologists, medical oncologists, physician assistants, nurse practitioners, and nurses who care for patients with blood cancers.

• Review genomic principles, terminology, technologies, and applications
• Describe available genomic tests for diagnosis of hematologic malignancies and relevant premalignant conditions

HOSTS

Michael Diaz, MD
Florida Cancer Specialists & Research Institute
St. Petersburg, Florida

Sanjay Juneja, MD
Mary Bird Perkins Cancer Center
Baton Rouge, Louisianna

INVITED EXPERTS

CLL

Jacqueline Barrientos, MD, MS
Mount Sinai Medical Center
Miami, Florida

Lymphoma
David Russler-Germain, MD, PhD
Washington University School of Medicine
St. Louis, Missouri

Myeloma
Ajai Chari, MD
Mount Sinai Cancer Clinical Trials Office
New York, New York

ALL
Emily K. Curran, MD
University of Cincinnati
Cincinnati, Ohio

AML
James Blachly, MD
The Ohio State University
Columbus, Ohio

MDS and Clonal Hematopoiesis
Namrata Chandhok, MD
University of Miami Health System
Miami, Florida

TFF, LLS and ASH require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF, LLS and ASH do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

This activity is supported by educational grants from Astellas, AbbVie, Daiichi Sankyo, Pharmacyclics, and Illumina.

The France Foundation, The Leukemia and Lymphoma Society, and the American Society of Hematology present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. TFF, LLS, ASH, and the commercial supporter(s) assume no liability for the information herein.

• The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
• Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.